Trial NCT03678506

View at ClinicalTrials.gov 
Org. Study IDs: FAA I1. 7-2017 (APIDULCIS)
Secondary IDs: 2017 002340 32

Last trial update was posted on 2023-02-24

MeSH Interventions

Apixaban

MeSH Conditions

Thromboembolism Venous Thromboembolism

Other Conditions

Anticoagulants

Stopping Reasons

The study was interrupted after a planned interim analysis for the high rate of primary outcomes (7.3%; 95% confidence interval [CI], 4.5-11.2)

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID